Madrid

• Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 Recruiting
  2023-509428-16-00 10 2024-10-15 HIV-1 Infection
• An international multicentric randomized phase II evaluating dostarlimab in combination with niraparib versus niraparib alone compared to ch … Recruiting
  2024-516782-36-00 4 2024-10-15 metastatic or recurrent endometrial or ovarian carcinosarcoma
• Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting
  2023-506224-87-00 4 2024-10-14 Recurring diverticulitis
• IDE196 (Darovasertib) in Combination with Crizotinib as First-line Therapy in Metastatic Uveal Melanoma Recruiting
  2023-506686-66-01 10 2024-10-09 HLA-A2 negative metastatic uveal melanoma
• Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting
  2024-511719-40-00 6 2024-10-09 Enterococcus faecalis infectious endocarditis
• 202301CPC Redefine-HF Recruiting
  2023-508581-15-00 5 2024-10-08 Heart condition
• Comparison between ABP 234 and Keytruda® (Pembrolizumab) Recruiting
  2024-514304-14-00 1 2024-10-08 Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer
• Treatment with darolutamide +/- radiation therapy for patients with a castration resistant cancer and metastases detected by functional imag … Recruiting
  2023-507482-26-00 5 2024-10-04 Castrate-resistant prostate cancer with oligometastases on functional
• Clinical trial comparing MK-2870 given with pembrolizumab to pembrolizumab alone in participants who have had surgery for NSCLC Recruiting
  2023-508012-35-00 5 2024-10-02 Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
• A Study to Evaluate ARV-393 in Adult Participants with Advanced Non-Hodgkin’s Lymphoma Recruiting
  2023-510136-36-00 1 2024-09-27 Advanced Non-Hodgkin’s Lymphoma
• First-in-human Trial of EGL-001 in Patients with Selected Advanced and/or Metastatic Solid Tumors Recruiting
  2024-512921-10-00 1 2024-09-27 Advanced and/or Metastatic Solid Tumors
• A Trial of Lu AG13909 in Adult Participants with Cushing’s Disease Recruiting
  2023-504733-53-00 4 2024-09-26 Cushing's Disease
• A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w … Recruiting
  2023-507064-39-00 5 2024-09-26 generalized Myasthenia Gravis
• A Phase 2/3 study to evaluate safety and efficacy of the combination of Bel- CHOP/ Fol-COP drugs against CHOP in newly diagnosed Peripheral … Recruiting
  2023-507803-76-00 10 2024-09-26 Peripheral T-Cell Lymphoma
• A Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis Recruiting
  2023-508429-29-00 4 2024-09-26 Progressive Pulmonary Fibrosis
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting
  2023-508811-21-00 10 2024-09-25 Refractory Focal Onset Epilepsy
• A clinical trial to learn about the safety and effects of STX-241, a new oral anticancer drug for the treatment of patients with advanced lu … Recruiting
  2023-510203-21-00 7 2024-09-24 locally advanced or metastatic non-small cell lung cancer (NSCLC) resi
• PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial Recruiting
  2024-514035-19-00 6 2024-09-23 infertility
• A study to characterise the safety, tolerability and efficacy of LY4170156 in subjects with advanced solid tumors Recruiting
  2024-511238-11-00 1 2024-09-20 Ovarian cancer, endometrial cancer, cervical cancer, non-small cell lu
• Preincisional versus postincisional ultrasound-guided transversus abdominis plane (TAP) block comparative effect on chronic postsurgical pai … Recruiting
  2024-513582-39-01 6 2024-09-20 Chronic postsurgical pain after open inguinal hernia mesh repair
• A Window of Opportunity Trial To Learn If Linvoseltamab Is Safe And Well Tolerated, And How Well It Works In adult Participants With Recentl … Recruiting
  2022-500800-24-00 4 2024-09-19 Multiple Myeloma
• Phase II Study to Assess the Efficacy of Niraparib Rechallenge after Surgery in Ovarian Cancer Patients with Oligometastatic Progression (Th … Recruiting
  2023-508258-24-00 4 2024-09-12 Ovarian cancer (OC) with oligometastatic progression (OMP).
• A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10 … Recruiting
  2023-507353-15-00 5 2024-09-10 idiopathic pulmonary fibrosis (IPF)
• HARMONi-3 Recruiting
  2024-513087-26-00 5 2024-09-10 Metastatic Non-small Cell Lung Cancer

Showing 1,273–1,296 of 3,550 trials